<DOC>
	<DOCNO>NCT01907854</DOCNO>
	<brief_summary>This trial conduct Asia , Europe North America . The aim trial investigate efficacy safety switch sitagliptin liraglutide subject type 2 diabetes achieve adequate glycaemic control sitagliptin metformin .</brief_summary>
	<brief_title>Efficacy Safety Switching From Sitagliptin Liraglutide Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control Sitagliptin Metformin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Informed consent obtain trialrelated activity . Trialrelated activity procedure carry part trial , include activity determine suitability trial Subjects diagnose type 2 diabetes treat metformin equal 1500 mg/day ( maximum tolerate dose equal 1000 mg/day ) sitagliptin 100 mg/day , stable dose least 90 day prior screen . Stable define unchanged medication dose HbA1c 7.5 % 9.5 % ( 58 mmol/mol 80 mmol/mol ) ( inclusive ) Body mass index equal 20 kg/m^2 Any chronic disorder severe disease discretion investigator might jeopardise subject 's safety compliance protocol Treatment glucose lower agent ( ) state inclusion criterion period 90 day prior screen . An exception shortterm treatment ( equal less 7 day total ) insulin connection intercurrent illness Female pregnant , breastfeeding , intend become pregnant childbearing potential use adequate contraceptive method ( adequate contraceptive measure require local regulation practice ) History chronic pancreatitis idiopathic acute pancreatitis Screening calcitonin value equal 50 ng/L Personal family history medullary thyroid carcinoma multiple endocrine neoplasia syndrome type 2 Diagnosis malignant neoplasm previous 5 year ( except basal cell skin cancer squamous cell skin cancer ) Impaired liver function , define alanine aminotransferase equal 2.5 time upper normal limit Impaired renal function define estimate glomerular filtration rate 60 mL/min/1.73 m^2 per modification diet renal disease formula Any episode unstable angina , acute coronary event , cerebral stroke/transient ischemic attack significant cardiovascular event judge investigator within 90 day prior screen Heart failure , New York Heart Association class IV Uncontrolled treat untreated hypertension ( systolic blood pressure equal 180 mmHg and/or diastolic blood pressure equal 100 mmHg )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>